Use of low-dose oral minoxidil during chemotherapy and antibody-drug conjugate therapy in patients with breast cancer: a retrospective cohort study

Name: Use of low-dose oral minoxidil during chemotherapy and antibody-drug conjugate therapy in patients with breast cancer: a retrospective cohort study
Creator: Caitlin Kearney
Published: 2025-08-31T04:42:40.371Z
Keywords: Chemotherapy, Breast Cancer, Minoxidil, Alopecia, Hair Loss

Kearney, Caitlin; Zaminski, Devyn; Brinks, Ann; Needle, Carli; Tattersall, Ian; Freites-Martinez, Azael; Garshick, Michael; Shapiro, Jerry; Mazori, Daniel; Lacouture, Mario; Lo Sicco, Kristen

doi:10.17632/hp4s3xp8mm.1

Use of low-dose oral minoxidil during chemotherapy and antibody-drug conjugate therapy in patients with breast cancer: a retrospective cohort study

Published: 31 August 2025| Version 1 | DOI: 10.17632/hp4s3xp8mm.1

Contributors:

Caitlin Kearney, Devyn Zaminski, Ann Brinks, Carli Needle, Ian Tattersall, Azael Freites-Martinez, Michael Garshick, Jerry Shapiro, Daniel Mazori, Mario Lacouture, Kristen Lo Sicco

Description

Supplementary Table I. Additional patient characteristics, including baseline cardiovascular comorbidities and cardiovascular or other relevant medications, not related to breast cancer or alopecia treatment, taken during the study period. Supplementary Figure I. Overview flowchart of the cohort analysis for inclusion criteria for this study.

Use of low-dose oral minoxidil during chemotherapy and antibody-drug conjugate therapy in patients with breast cancer: a retrospective cohort study

Description

Files

Categories

Licence